Asia’s 2020 nat cat losses highlight lack of cover: Munich Re
January 8 2021 by Andrew Tjaardstra
-
NZ non-life segment growth to remain robust even as carriers adjust rates: AM Best
- November 11
In its latest report on the segment, the rating agency has maintained a stable outlook citing solid premium growth supported by rate adjustments.
-
PCRIC, WTW renew Pacific islands reinsurance portfolio
- November 7
The Pacific Islands captive has developed new policy designs with the support from WTW’s disaster risk finance and alternative risk transfer teams.
-
Hurricane Milton, German floods to drive rates up: Peak Re’s Nowakowski
- November 7
Civil commotion and political instability are additional factors that reinsurers must consider, said the chief underwriting officer.
-
APAC reinsurers face profitability, diversification, and risk management challenges: S&P Global
- November 7
Wenwen Chen, director at S&P Global discusses key factors influencing the profitability of APAC reinsurers and the impact of retrocession costs.
-
BHSI | Managing non-Asian exposure in long-tail lines
While US-exposed business can look attractive to Asian carriers, managing the volatility around the long-term results and the ability to model those losses are crucial, say BHSI’s Marc Breuil and Marcus Portbury.
-
Sedgwick | To Handle CAT Claims Well, Multi-Step Preparation is Key
When it comes to risk, it’s not a matter of “if” it’s a matter of “when” an event will occur.
-
HSBC Asset Management | Is it time to relook at Asian currency bonds?
With diversification and performance high on investors’ agendas, it seems a good time for global portfolios to revive allocations in Asian local currency bonds – including Hong Kong dollar (HKD) bonds.
-
PineBridge Investments | Why Asian insurers are exploring private credit and CLOs
The recent rollout of risk-based capital regimes across Asia calls for a closer alignment between insurers’ assets and liabilities. We explore potential ways to maintain a healthy investment yield and robust returns on regulatory capital.
